Search

everythinglearnresearchcommunity

for

Search:↓

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The FDA approved a new Pfizer drug for hair loss in teens.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Piptadeniastrum africanum and Cordia plathytyrsa can increase testosterone without major metabolic changes, but may affect triglycerides and creatinine.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

A new method improves platelet testing for heart disease patients.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

The method accurately measures finasteride in plasma, and the test tablets are as effective as the reference ones.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

Isotretinoin is safe and effective for acne, with common side effects like dry lips; serious side effects are rare.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Metformin lowers prolactin in men with normal hair but not in those with early hair loss.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The new method for making Finasteride is cheaper and safer for large-scale production.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

DA-9401 helps protect rat testis from finasteride damage.